Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials
Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.
December 8, 2025
4 minutes
Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.
.png)
